A non-randomized, open-label study of the safety and effectiveness

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab

A non-randomized, open-label study of the safety and effectiveness of a novel non-pneumatic compression device (NPCD) for lower limb lymphedema

Effects of open-label placebos on test performance and

Epidemiology and Clinical Research Design, Part 1: Study Types

Epidemiology and Clinical Research Design, Part 1: Study Types

Randomized controlled trial - Wikipedia

On Biostatistics and Clinical Trials: Randomized Withdrawal Design

Dostarlimab or pembrolizumab plus chemotherapy in previously

Pharmaceutics, Free Full-Text

Disturbed Thought Processes (Cognitive Impairment) Nursing

PDF) Superior Clinical, Quality of Life, Functional, and Health Economic Outcomes with Pneumatic Compression Therapy for Lymphedema

Master Protocols to Study Multiple Therapies, Multiple Diseases

NIH launches long COVID clinical trials through RECOVER Initiative